Shaw LM - Search Results

1

First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays.

Boulo S, Kuhlmann J, Andreasson U, Brix B, Venkataraman I, Herbst V, Rutz S, Manuilova E, Vandijck M, Dekeyser F, Bjerke M, Pannee J, Charoud-Got J, Auclair G, Mazoua S, Pinski G, Trapmann S, Schimmel H, Emons H, Quaglia M, Portelius E, Korecka M, Shaw LM, Lame M, Chambers E, Vanderstichele H, Stoops E, Leinenbach A, Bittner T, Jenkins RG, Kostanjevecki V, Lewczuk P, Gobom J, Zetterberg H, Zegers I, Blennow K. Boulo S, et al. Among authors: shaw lm. Alzheimers Dement. 2020 Nov;16(11):1493-1503. doi: 10.1002/alz.12145. Epub 2020 Aug 4. Alzheimers Dement. 2020. PMID: 32755010 Free PMC article.

2

Monitoring of mycophenolic acid in clinical transplantation.

Shaw LM, Pawinski T, Korecka M, Nawrocki A. Shaw LM, et al. Ther Drug Monit. 2002 Feb;24(1):68-73. doi: 10.1097/00007691-200202000-00012. Ther Drug Monit. 2002. PMID: 11805725 Review. No abstract available.

3

Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses.

Majewski M, Korecka M, Joergensen J, Fields L, Kossev P, Schuler W, Shaw L, Wasik MA. Majewski M, et al. Transplantation. 2003 May 27;75(10):1710-7. doi: 10.1097/01.TP.0000063934.89714.19. Transplantation. 2003. PMID: 12777861

4

Using established immunosuppressant therapy effectively: lessons from the measurement of mycophenolic acid plasma concentrations.

Shaw LM, Nawrocki A, Korecka M, Solari S, Kang J. Shaw LM, et al. Ther Drug Monit. 2004 Aug;26(4):347-51. doi: 10.1097/00007691-200408000-00002. Ther Drug Monit. 2004. PMID: 15257062 Review.

5

Accidental intravenous colchicine poisoning.

Sussman JS, Brozena SC, Skop N, Korecka M, Shaw LM. Sussman JS, et al. Among authors: shaw lm. Ther Drug Monit. 2004 Dec;26(6):688-92. doi: 10.1097/00007691-200412000-00017. Ther Drug Monit. 2004. PMID: 15570196

6

Sensitive, high throughput HPLC-MS/MS method with on-line sample clean-up for everolimus measurement.

Korecka M, Solari SG, Shaw LM. Korecka M, et al. Among authors: shaw lm. Ther Drug Monit. 2006 Aug;28(4):484-90. doi: 10.1097/00007691-200608000-00002. Ther Drug Monit. 2006. PMID: 16885715

7

HPLC-atmospheric pressure chemical ionization MS/MS for quantification of 15-F2t-isoprostane in human urine and plasma.

Haschke M, Zhang YL, Kahle C, Klawitter J, Korecka M, Shaw LM, Christians U. Haschke M, et al. Among authors: shaw lm. Clin Chem. 2007 Mar;53(3):489-97. doi: 10.1373/clinchem.2006.078972. Epub 2007 Jan 26. Clin Chem. 2007. PMID: 17259231

8

Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics.

Shaw LM, Korecka M, Clark CM, Lee VM, Trojanowski JQ. Shaw LM, et al. Nat Rev Drug Discov. 2007 Apr;6(4):295-303. doi: 10.1038/nrd2176. Epub 2007 Mar 9. Nat Rev Drug Discov. 2007. PMID: 17347655 Review.

9

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative. Shaw LM, et al. Ann Neurol. 2009 Apr;65(4):403-13. doi: 10.1002/ana.21610. Ann Neurol. 2009. PMID: 19296504 Free PMC article.

10

Review of the newest HPLC methods with mass spectrometry detection for determination of immunosuppressive drugs in clinical practice.

Korecka M, Shaw LM. Korecka M, et al. Among authors: shaw lm. Ann Transplant. 2009 Apr-Jun;14(2):61-72. Ann Transplant. 2009. PMID: 19487797 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

724 results

Search Page